Profil
Leodevico L.
Ilag was the founder of Xerion Pharmaceuticals AG, serving as MD, Chief Scientific & Technology Officer from 1998 to 2004.
Dr. Ilag is currently a Non-Executive Director at Plentex Ltd. since 2021.
Former positions include Chief Operating Officer at Patrys Ltd. and Chief Scientific Officer at Manalto Ltd.
Postes actifs de Leodevico L. Ilag
| Sociétés | Poste | Début |
|---|---|---|
| PLENTEX LIMITED | Directeur/Membre du Conseil | 22/07/2021 |
Anciens postes connus de Leodevico L. Ilag
| Sociétés | Poste | Fin |
|---|---|---|
Xerion Pharmaceuticals AG
Xerion Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Develops antibodies and therapeutic targets | Fondateur | 01/01/2004 |
| MANALTO LIMITED | Directeur Technique/Scientifique/R&D | - |
| PATRYS LIMITED | Directeur des opérations | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Patrys Ltd.
Patrys Ltd. Pharmaceuticals: MajorHealth Technology Develops novel antibody technologies for hard-to-treat cancers | Health Technology |
Plentex Ltd.
Plentex Ltd. Agricultural Commodities/MillingProcess Industries Produces, develops and supplies algae oil to the biological and fuel industry | Process Industries |
Manalto Ltd.
Manalto Ltd. Packaged SoftwareTechnology Services Develops and commercializes social media management software | Technology Services |
Xerion Pharmaceuticals AG
Xerion Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Develops antibodies and therapeutic targets | Health Technology |
















